2002, Volume 09, Issue 02, pages 57-124
CLINICAL ARTICLE
Br J Cardiol 2002;9:120-21
Myocardial infarction in a patient with hypertrophic cardiomyopathy Hypertrophic cardiomyopathy (HC) is a disease characterised by marked heterogeneity in its morphology and natural history. The...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:115-19
One of the purposes of the United Kingdom Prospective Diabetes Study (UKPDS) was to compare the efficacy of different antidiabetic drugs in the long-term treatment...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:109-14
The objective of this paper was to quantify the impact on overall cardiovascular disease treatment costs resulting from the use of amlodipine in the coronary...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:106-8
We studied the potential benefits of using lead V4R during routine exercise treadmill testing for patients undergoing district general hospital investigation for suspected coronary artery...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:103-5
Defining prognosis may be helpful in planning acute treatment of stroke, setting rehabilitation goals and setting resource priorities. Case fatality is 12% within the first...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:99-102
Atrial septal defects are a common form of congenital heart disease that can present at any age, even in the elderly. As symptoms may be...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:92-8
Some 340 adult patients (186 male, 154 female; average age 36 years) with congenital heart disease are now seen in a dedicated clinic at a...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:68-71
Myocardial ischaemia is a reliable predictor of significant coronary artery disease (CAD). During an episode of myocardial ischaemia, anginal pain may appear late or not...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:65-67
Adult congenital heart disease: time for a national framework Michael A Gatzoulis Congenital heart disease (CHD) is one of the most common inborn defects, occurring...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:
This supplement has been sponsored by Merck Sharp & Dohme Limited. It features highlights from a meeting "Changing the course of cardiovascular disease", which was...
Read More
CLINICAL ARTICLE
Br J Cardiol 2002;9:54-6
Though the evidence for secondary prevention of cardiovascular disease is strong, the substantial benefits in terms of outcomes are often lost at practice level with...
Read More